Ezra Y Rosen

11PUBLICATIONS
127CO-AUTHORS
Predictive and prognostic markersEnvironmental epidemiologyMolecular targetsOncology and carcinogenesis not elsewhere classifiedHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 24, 2026
The Genomic Landscape of MYC-, MYCL-, and MYCN-Amplified Solid Tumors.

|May 05, 2026
Benralizumab for Eosinophil-Related Cutaneous Adverse Events of Anticancer Therapy: A Phase II Trial.

|Jan 21, 2026
Camonsertib, an ATRi, in Combination with Low-Dose Gemcitabine in Solid Tumors with DNA Damage Response Aberrations: Preclinical and Phase Ib Results.

Ezra Y Rosen, Timothy A Yap, Elisa Fontana

|Jul 24, 2025
Genomic and Epigenomic ctDNA Profiling in Liquid Biopsies from Heavily Pretreated Patients with DNA Damage Response-Deficient Tumors.

Ian M Silverman, Joseph D Schonhoft, Benjamin Herzberg

|Aug 07, 2024
Genotype-Directed Synthetic Cytotoxicity of ATR Inhibition with Radiotherapy.

Victor Ng, Sonali Sinha, Ardijana Novaj

|Jul 28, 2024
Pathologic complete response to KEYNOTE522 and HER2-directed therapy for synchronous TNBC and HER2+ breast cancer.

Nicholas Mai, Jie-Fu Chen, Satshil Rana

Pageof 2